Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Effects of synephrine and beta-phenethylamine on human alpha-adrenoceptor subtypes.

Ma G, Bavadekar SA, Schaneberg BT, Khan IA, Feller DR.

Planta Med. 2010 Jul;76(10):981-6. doi: 10.1055/s-0029-1240884. Epub 2010 Mar 9.

PMID:
20217639
2.

Bioisosteric phentolamine analogs as selective human alpha(2)- versus alpha(1)-adrenoceptor ligands.

Bavadekar SA, Hong SS, Lee SI, Miller DD, Feller DR.

Eur J Pharmacol. 2008 Aug 20;590(1-3):53-60. doi: 10.1016/j.ejphar.2008.05.027. Epub 2008 May 29.

PMID:
18589415
3.

Pharmacological effects of ephedrine alkaloids on human alpha(1)- and alpha(2)-adrenergic receptor subtypes.

Ma G, Bavadekar SA, Davis YM, Lalchandani SG, Nagmani R, Schaneberg BT, Khan IA, Feller DR.

J Pharmacol Exp Ther. 2007 Jul;322(1):214-21. Epub 2007 Apr 3.

PMID:
17405867
4.

Tethered yohimbine analogs as selective human alpha2C-adrenergic receptor ligands.

Bavadekar SA, Ma G, Mustafa SM, Moore BM, Miller DD, Feller DR.

J Pharmacol Exp Ther. 2006 Nov;319(2):739-48. Epub 2006 Jul 27.

PMID:
16873606
6.

1-Benzyl-1,2,3,4-tetrahydroisoquinoline-6,7-diols as novel affinity and photoaffinity probes for beta-adrenoceptor subtypes.

Nikulin VI, Rakov IM, De Los Angeles JE, Mehta RC, Boyd LY, Feller DR, Miller DD.

Bioorg Med Chem. 2006 Mar 15;14(6):1684-97. Epub 2006 Jan 20.

PMID:
16431119
7.

Bioisosteric phentolamine analogs as potent alpha-adrenergic antagonists.

Hong SS, Bavadekar SA, Lee SI, Patil PN, Lalchandani SG, Feller DR, Miller DD.

Bioorg Med Chem Lett. 2005 Nov 1;15(21):4691-5.

PMID:
16153828
8.

Synthesis and biological studies of yohimbine derivatives on human alpha2C-adrenergic receptors.

Mustafa SM, Bavadekar SA, Ma G, Moore BM, Feller DR, Miller DD.

Bioorg Med Chem Lett. 2005 Jun 2;15(11):2758-60.

PMID:
15911252
9.
10.

Medetomidine analogs as selective agonists for the human alpha2-adrenoceptors.

Lalchandani SG, Zhang X, Hong SS, Liggett SB, Li W, Moore BM 2nd, Miller DD, Feller DR.

Biochem Pharmacol. 2004 Jan 1;67(1):87-96.

PMID:
14667931
11.

Evaluation of beta-adrenergic receptor subtypes in the human prostate cancer cell line-LNCaP.

Nagmani R, Pasco DS, Salas RD, Feller DR.

Biochem Pharmacol. 2003 May 1;65(9):1489-94.

PMID:
12732361
12.

Yohimbine dimers exhibiting selectivity for the human alpha 2C-adrenoceptor subtype.

Lalchandani SG, Lei L, Zheng W, Suni MM, Moore BM, Liggett SB, Miller DD, Feller DR.

J Pharmacol Exp Ther. 2002 Dec;303(3):979-84.

PMID:
12438517
13.

Pseudolaric acid analogs as a new class of peroxisome proliferator-activated receptor agonists.

Jaradat MS, Noonan DJ, Wu B, Avery MA, Feller DR.

Planta Med. 2002 Aug;68(8):667-71. Erratum in: Planta Med. 2003 Aug;69(8):784. Jardat Maisa S [corrected to Jaradat Maisa S].

PMID:
12221584
14.

Synthesis and in vitro platelet aggregation and TP receptor binding studies on bicyclic 5,8-ethanooctahydroisoquinolines and 5,8-ethanotetrahydroisoquinolines.

Saha SL, Roche VF, Pendola K, Kearley M, Lei L, Romstedt KJ, Herdman M, Shams G, Kaisare V, Feller DR.

Bioorg Med Chem. 2002 Aug;10(8):2779-93.

PMID:
12057668
15.

Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin.

Jaradat MS, Wongsud B, Phornchirasilp S, Rangwala SM, Shams G, Sutton M, Romstedt KJ, Noonan DJ, Feller DR.

Biochem Pharmacol. 2001 Dec 15;62(12):1587-95.

PMID:
11755111
16.

Biochemical activities of trimetoquinol analogs at human beta(1)- and beta(3)-adrenergic receptors.

Konkar AA, Nikulin VI, De Los Angeles J, Hong SS, Fertel RH, Miller DD, Feller DR.

Pharmacology. 2001 Jan;62(1):45-55.

PMID:
11150922
17.

Yohimbine dimers exhibiting binding selectivities for human alpha2a- versus alpha2b-adrenergic receptors.

Zheng W, Lei L, Lalchandani S, Sun G, Feller DR, Miller DD.

Bioorg Med Chem Lett. 2000 Apr 3;10(7):627-30.

PMID:
10762040
18.
19.

Biochemical and functional characterization of 1-benzyl substituted trimetoquinol affinity analogs on rat and human beta-adrenoceptors.

Mehta RC, Salazar-Bookaman MM, Fertel RH, De Los Angeles J, Nikulin VI, Fraundorfer PF, Miller DD, Feller DR.

Biochem Pharmacol. 2000 Mar 1;59(5):517-29.

PMID:
10660118
20.

Beta-adrenoceptor subtype activities of trimetoquinol derivatives: biochemical studies on human beta-adrenoceptors expressed in chinese hamster ovary cells.

Konkar AA, Vansal SS, Shams G, Fraundorfer PF, Zheng WP, Nikulin VI, De Los Angeles J, Fertel RH, Miller DD, Feller DR.

J Pharmacol Exp Ther. 1999 Nov;291(2):875-83.

PMID:
10525112
21.

Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes.

Vansal SS, Feller DR.

Biochem Pharmacol. 1999 Sep 1;58(5):807-10.

PMID:
10449190
22.

2-Amino-4-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridines: novel selective beta3-adrenoceptor agonists.

Zheng W, Nikulin VI, Konkar AA, Vansal SS, Shams G, Feller DR, Miller DD.

J Med Chem. 1999 Jun 17;42(12):2287-94.

PMID:
10377236
23.

An efficient cyclic AMP assay for the functional evaluation of beta-adrenergic receptor ligands.

Vansal SS, Feller DR.

J Recept Signal Transduct Res. 1999 Sep;19(5):853-63.

PMID:
10349598
24.

Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids.

Intrasuksri U, Rangwala SM, O'Brien M, Noonan DJ, Feller DR.

Gen Pharmacol. 1998 Aug;31(2):187-97.

PMID:
9688458
25.

Activation of L-type calcium channel by tolazoline derivatives: role of isothiocyanate moiety.

Lei L, Vaghy PL, Slavica M, De Los Angeles J, Smith B, Miller DD, Feller DR.

J Cardiovasc Pharmacol. 1998 May;31(5):721-33.

PMID:
9593072
26.
27.

Beta-adrenergic receptor and platelet inhibitory activities of a new series of trimetoquinol and related benzazepine analogs.

Shams G, Romstedt KJ, Lust LA, Clark MT, Miller DD, Feller DR.

Gen Pharmacol. 1997 Feb;28(2):323-30.

PMID:
9013212
28.

Synthesis and evaluation of trimetoquinol derivatives: novel thromboxane A2/prostaglandin H2 antagonists with diminished beta-adrenergic agonist activity.

Christoff JJ, Bradley L, Miller DD, Lei L, Rodriguez F, Fraundorfer P, Romstedt K, Shams G, Feller DR.

J Med Chem. 1997 Jan 3;40(1):85-91.

PMID:
9016331
29.
30.

Structural requirements of chiral clofibric acid analogs for activation of the rat peroxisome proliferator-activated receptor alpha.

Feller DR, O'Brien M, Rangwala SM, Tortorella V, Loiodice F, Noonan DJ.

Ann N Y Acad Sci. 1996 Dec 27;804:713-5. No abstract available.

PMID:
8993602
31.

Iodinated analogs of trimetoquinol as highly potent and selective beta 2-adrenoceptor ligands.

De Los Angeles JE, Nikulin VI, Shams G, Konkar AA, Mehta R, Feller DR, Miller DD.

J Med Chem. 1996 Sep 13;39(19):3701-11.

PMID:
8809159
32.

Medetomidine analogs as alpha 2-adrenergic ligands. 2. Design, synthesis, and biological activity of conformationally restricted naphthalene derivatives of medetomidine.

Zhang X, Yao XT, Dalton JT, Shams G, Lei L, Patil PN, Feller DR, Hsu FL, George C, Miller DD.

J Med Chem. 1996 Jul 19;39(15):3001-13.

PMID:
8709134
33.

Pharmacological study of atypical beta-adrenoceptors in rat esophageal smooth muscle.

Lezama EJ, Konkar AA, Salazar-Bookaman MM, Miller DD, Feller DR.

Eur J Pharmacol. 1996 Jul 11;308(1):69-80.

PMID:
8836634
34.

Pharmacological activities of trimetoquinol and 1-benzyl halogen-substituted analogues on rat beta-adrenoceptor subtypes.

Konkar AA, Fraundorfer PF, Fertel RH, Burkman AM, Miller DD, Feller DR.

Eur J Pharmacol. 1996 Jun 3;305(1-3):63-71.

PMID:
8813533
35.

Differential eudismic ratios in the antagonism of human platelet function by phenoxy- and thiophenoxyacetic acids.

Romstedt KJ, Lei LP, Feller DR, Witiak DT, Loiodice F, Tortorella V.

Farmaco. 1996 Feb;51(2):107-14.

PMID:
8857205
36.

Convergence of three steroid receptor pathways in the mediation of nongenotoxic hepatocarcinogenesis.

O'Brien ML, Rangwala SM, Henry KW, Weinberger C, Crick DC, Waechter CJ, Feller DR, Noonan DJ.

Carcinogenesis. 1996 Feb;17(2):185-90.

PMID:
8625436
37.
38.

A structure-activity relationship study of benzylic modifications of 4-[1-(1-naphthyl)ethyl]-1H-imidazoles on alpha 1- and alpha 2-adrenergic receptors.

Hong SS, Romstedt KJ, Feller DR, Hsu FL, Cupps TL, Lyon RA, Miller DD.

J Med Chem. 1994 Jul 22;37(15):2328-33.

PMID:
7914537
39.

Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.

Slavica M, Lei L, Patil PN, Kerezy A, Feller DR, Miller DD.

J Med Chem. 1994 Jun 10;37(12):1874-81.

PMID:
8021927
40.

Isomeric-activity ratios of trimetoquinol enantiomers on beta-adrenergic receptor subtypes: functional and biochemical studies.

Fraundorfer PF, Lezama EJ, Salazar-Bookaman MM, Fertel RH, Miller DD, Feller DR.

Chirality. 1994;6(2):76-85.

PMID:
7911313
41.

Halogen-substituted trimetoquinol analogs as thromboxane A2 receptor antagonists in platelets and aorta.

Romstedt KJ, Shin Y, Shams G, Doyle K, Tantishaiyakul V, Clark MT, Adejare A, Hamada A, Miller DD, Feller DR.

Biochem Pharmacol. 1993 Dec 3;46(11):2051-9.

PMID:
8267653
43.

Inhibition of low density lipoprotein oxidation by thyronines and probucol.

Hanna AN, Feller DR, Witiak DT, Newman HA.

Biochem Pharmacol. 1993 Feb 9;45(3):753-62.

PMID:
8442772
44.

Synthesis and alpha-adrenergic activities of 2- and 4-substituted imidazoline and imidazole analogues.

Amemiya Y, Hong SS, Venkataraman BV, Patil PN, Shams G, Romstedt K, Feller DR, Hsu FL, Miller DD.

J Med Chem. 1992 Feb 21;35(4):750-5.

PMID:
1347319
45.

Synthesis of halogenated trimetoquinol derivatives and evaluation of their beta-agonist and thromboxane A2 (TXA2) antagonist activities.

Markovich KM, Tantishaiyakul V, Hamada A, Miller DD, Romstedt KJ, Shams G, Shin Y, Fraundorfer PF, Doyle K, Feller DR.

J Med Chem. 1992 Feb 7;35(3):466-79.

PMID:
1346651
46.

Resolution and adrenergic activities of the optical isomers of 4-[1-(1-naphthyl)ethyl]-1H-imidazole.

Hong SS, Romstedt KJ, Feller DR, Hsu FL, George C, Cupps TL, Lyon RA, Miller DD.

Chirality. 1992;4(7):432-8.

PMID:
1361151
48.

Structure-activity studies of new imidazolines on adrenoceptors of rat aorta and human platelets.

Venkataraman BV, Shams G, Hamada A, Amemiya Y, Tantishaiyakul V, Hsu F, Fashempour J, Romstedt KJ, Miller DD, Feller DR, et al.

Naunyn Schmiedebergs Arch Pharmacol. 1991 Oct;344(4):454-63.

PMID:
1766472
49.

Diversity of the pharmacological actions of some tolazoline analogues in human platelets and rat aorta.

Shams G, Venkataraman BV, Hamada A, Miller DD, Patil PN, Feller DR.

Eur J Pharmacol. 1991 Jul 9;199(3):315-23.

PMID:
1655482
50.

Supplemental Content

Loading ...
Support Center